Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 17;32(4):631-642.e7.
doi: 10.1016/j.chembiol.2025.03.004. Epub 2025 Apr 9.

Molecular mechanism of PP2A/B55α phosphatase inhibition by IER5

Affiliations

Molecular mechanism of PP2A/B55α phosphatase inhibition by IER5

Ruili Cao et al. Cell Chem Biol. .

Abstract

PP2A serine/threonine phosphatases are heterotrimeric complexes that execute many essential physiologic functions. These activities are modulated by additional regulatory proteins, such as ARPP19, FAM122A, and IER5. Here, we report the cryoelectron microscopy (cryo-EM) structure of a complex of PP2A/B55α with the N-terminal structured region of IER5 (IER5-N50), which occludes a surface on B55α used for substrate recruitment, and show that IER5-N50 inhibits PP2A/B55α catalyzed dephosphorylation of pTau in biochemical assays. Mutations of full-length IER5 that disrupt its PP2A/B55α interface interfere with co-immunoprecipitation of PP2A/B55α. IER5 antagonism of B55α in keratinocytes is required for expression of KRT1, a differentiation marker. Mini-IER5 composed of IER5-N50 and a nuclear localization sequence restores this activity in IER5 knockout cells. Using structural bioinformatics, we identify homology of IER5-N50 with SERTA (SEI-1, RBT-1, and TARA) domain containing proteins. These studies define the molecular basis of PP2A/B55α nuclear inhibition by IER5 and suggest a roadmap for selective pharmacologic modulation of PP2A/B55α complexes.

Keywords: Alphafold; Foldseek; KRT1; cryoelectron microscopy; immediate early response genes; nuclear localization; protein phosphatase 2A; structure prediction.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.C.B. is on the board of directors of the non-profit Institute for Protein Innovation and the Revson Foundation; is on the scientific advisory board for and receives funding from Erasca, Inc. for an unrelated project; is an advisor to MPM Capital; and is a consultant for IFM, Scorpion Therapeutics, Odyssey Therapeutics, Droia Ventures, and Ayala Pharmaceuticals for unrelated projects. J.C.A. is a consultant for Ayala Pharmaceuticals, Cellestia, Inc., SpringWorks Therapeutics, and Remix Therapeutics.

Update of

References

    1. Amin P, Awal S, Vigneron S, Roque S, Mechali F, Labbé JC, Lorca T, and Castro A (2021). PP2A-B55: substrates and regulators in the control of cellular functions. Oncogene 2021 41:1 41, 1–14. 10.1038/s41388-021-02068-x. - DOI - PubMed
    1. Grallert A, Boke E, Hagting A, Hodgson B, Connolly Y, Griffiths JR, Smith DL, Pines J, and Hagan IM (2015). A PP1/PP2A phosphatase relay controls mitotic progression. Nature 517, 94. 10.1038/NATURE14019. - DOI - PMC - PubMed
    1. Krasinska L, Domingo-Sananes MR, Kapuy O, Parisis N, Harker B, Moorhead G, Rossignol M, Novák B, and Fisher D (2011). Protein phosphatase 2A controls the order and dynamics of cell-cycle transitions. Molecular cell 44, 437–450. 10.1016/J.MOLCEL.2011.10.007. - DOI - PubMed
    1. Swartz SZ, Nguyen HT, McEwan BC, Adamo ME, Cheeseman IM, and Kettenbach AN (2021). Selective dephosphorylation by pp2a-b55 directs the meiosis imeiosis ii transition in oocytes. eLife 10. 10.7554/ELIFE.70588. - DOI - PMC - PubMed
    1. Wurzenberger C, and Gerlich DW (2011). Phosphatases: providing safe passage through mitotic exit. Nature Reviews Molecular Cell Biology 2011 12:8 12, 469–482. 10.1038/nrm3149. - DOI - PubMed

MeSH terms

LinkOut - more resources